West Bloomfield, MI, United States of America

Adhip P N Majumdar

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, Other. Active years: 2002-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adhip P N Majumdar. Retrieved from https://idiyas.com/inventor/adhip-p-n-majumdar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 1.2

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Adhip P N Majumdar

Introduction

Adhip P N Majumdar is an accomplished inventor based in West Bloomfield, MI (US). He has made significant contributions to the field of biomedical research, particularly in the development of antibodies and proteins related to the epidermal growth factor receptor (EGFR). With a total of 3 patents, his work has the potential to impact diagnostic and therapeutic strategies for various malignancies.

Latest Patents

One of his notable inventions is the development of antibodies to a novel EGF-receptor related protein (ERRP). This invention focuses on ERRP-specific antibodies that can be utilized to study the functional properties of ERRP and serve as diagnostic and prognostic tools for malignancies. The antibody is designed to react with a segment of ERRP containing 15 amino acids, which possesses significant antigenic properties.

Another significant patent involves recombinant DNA encoding an epidermal growth factor receptor related protein. This patent describes a cDNA fragment clone of 1583 base pairs that shows 90-95% sequence homology to mouse EGFR and a truncated rat EGFR. The isolated cDNA, termed ERRP, has been shown to hybridize strongly to a mRNA transcript of about 1.8 kb in Northern-blot analysis. Maximal expression of ERRP was noted in the small intestine, followed by the colon, liver, gastric mucosa, and other tissues. Transfection of ERRP cDNA in HCT-116 cells, a colon cancer cell line, significantly inhibits proliferation and delays tumor growth in SCID mice.

Career Highlights

Throughout his career, Adhip P N Majumdar has worked with various organizations, including the United States Government as represented by the Department of Veterans Affairs. His research has contributed to a deeper understanding of the EGFR gene family and its implications in cancer biology.

Collaborations

Adhip has collaborated with notable professionals in his field, including Fazlul H Sarkar. Their joint efforts have further advanced the research surrounding ERRP and its potential applications in cancer treatment.

Conclusion

Adhip P N Majumdar's innovative work in the field of biomedical research highlights the importance of developing targeted therapies for malignancies. His contributions through patents and collaborations continue to pave the way for advancements in cancer diagnostics and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…